Cardiovascular Profile of Xanthone-Based 1,4 Dihydropyridines Bearing a Lidoflazine Pharmacophore Fragment.

As a follow-up to our previous studies on differently substituted 1,4-dihydropyridines endowed with a peculiar cardiac selectivity, in this paper, a small series of hybrid compounds bearing the pharmacophore fragment of lidoflazine in position 2 or 3 on a 4-(xanthen-9-one)-dihydropyridine core was reported. Lidoflazine was selected due to our promising previously reported data, and the xanthen-9-one substituent was introduced in position 4 of the dihydropyridine scaffold based on the cardiac selectivity observed in several of our studies. The new hybrid compounds were tested to assess cardiac and vascular activities, and the data were evaluated in comparison with those previously obtained for 4-(xanthen-9-one)-dihydropyridines and lidoflazine⁻nifedipine hybrid compounds. The functional studies indicated an interesting peculiar selectivity for the cardiac parameter inotropy, in particular when the lidoflazine fragment was introduced in position 2 of the dihydropyridine scaffold (4a⁻e), and thus a possible preferential binding with the Cav 1.2 isoform of l-type calcium channels, which are mainly involved in cardiac contractility.

Síntese de derivados diidrofurânicos, `alfa'-metilenolactonas e dos princípios ativos lidoflazina e PR-608 / Synthesis of dihydrofurans derivatives, alpha-methylene lactones and biologically actives lidoflazine and PR608

A primeira parte deste trabalho refere-se às reações de ciclofuncionalização, utilizando, como agentes eletrofílicos, indutores de ciclofuncionalização, iodo, brometo de fenilselenenila e tricloreto de p-metoxifeniltelúrio. Na primeira etapa, foram sintetizados compostos 1,3-dicarbonílicos 2,4-dialilsubstituídos, com os grupos alila, crotila e cicloexenila, respectivamente. Os compostos 1,3-dicarbonílicos 2,4-dialilsubstituídos foram submetidos a reações de monociclofuncionalização, produzindo éteres cíclicos funcionalizados, com ligação dupla endocíclica e exocíclica, conforme o esquema ilustrativo a seguir. Com a utilização de iodo em excesso, foi possível obter `alfaï-metilenolactonas ligadas a um anel tetraidrofurânico. A segunda parte deste trabalho refere-se à síntese dos princípios ativos lidoflazina, com atividade vasodilatadora coronariana, e PR-608, com atividade anti-parkinsoniana...

[Lidoflazine derivatives with cycloaliphatic residues of coronary dilator activity]. / Derivati della lidoflazina con residui cicloalifatici ad attività coronarodilatatrice.

The preparation of some derivatives of lidoflazine bearing a phenylcyclohexane residue in place of the m.xylene is described. Study of the coronary dilating activity on the isolated heart showed that this activity is markedly increased by the modification. Acute toxicity in rats is also strongly increased.